Reprogramming Photosensitization Mechanisms for Hypoxic Tumor Therapy via Organic Photovoltaic‐Inspired Heterojunctions
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.9966547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Shirong Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Rose Bengal, Tumor Hypoxia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, the Interdisciplinary Research Center of Beijing University of Chemical Technology.
Abstract (Originalsprache)
Conventional Type II photodynamic therapy (PDT) is severely compromised by tumor hypoxia. Drawing inspiration from the charge‐separation principles of organic photovoltaics (OPV), we herein show that a molecularly predefined donor‐acceptor interface can re‐route the excited‐state fate of a classical Type II photosensitizer. Electrostatic co‐assembly of cationic Y6‐2Pr with anionic Rose Bengal (RB) furnishes a stoichiometrically defined 1:2 heterojunction, in which ultrafast intermolecular electron transfer gives rise to an interfacial charge‐transfer‐to‐charge‐separated (CT → CS) evolution. This process strongly attenuates triplet‐mediated singlet‐oxygen sensitization and redirects the photochemistry of RB toward a hypoxia‐tolerant Type I pathway dominated by superoxide generation. The photogenerated holes concurrently oxidize NADH, establishing an interfacial photoredox cycle that weakens intracellular reductive defense. By translating a central concept of organic photovoltaic interfaces to photomedicine at the level of a stoichiometrically defined molecular complex, this work provides a route to retrofit classical Type II photosensitizers with Type I photoredox function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.
- Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China.
ORCID-Profile: Shirong Yan, Wu-Jie Guo, Ben Zhong Tang, Hui-Qing Peng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- the Interdisciplinary Research Center of Beijing University of Chemical Technology
Zitieren
APA
Yan, S., Qiao, L., Guo, W. J., Xu, S., Qi, T., Tang, B. Z., & Peng, H. Q. (2026). Reprogramming Photosensitization Mechanisms for Hypoxic Tumor Therapy via Organic Photovoltaic‐Inspired Heterojunctions. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.9966547
Vancouver
Yan S, Qiao L, Guo WJ, Xu S, Qi T, Tang BZ, et al. Reprogramming Photosensitization Mechanisms for Hypoxic Tumor Therapy via Organic Photovoltaic‐Inspired Heterojunctions. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.9966547
BibTeX
@article{Yan2026,
author = {Yan, Shirong and Qiao, Lu and Guo, Wu-Jie and Xu, Shihao and Qi, Tongfei and Tang, Ben Zhong and Peng, Hui-Qing},
title = {Reprogramming Photosensitization Mechanisms for Hypoxic Tumor Therapy via Organic Photovoltaic‐Inspired Heterojunctions},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.9966547}
}
EUVIMED